PURCHASE - Cognition Therapeutics, Inc., , a clinical stage company developing drugs that treat neurodegenerative disorders, provided a recap of the virtual KOL event hosted on April 12, 2024.
NEW YORK, April 01, 2024 Cognition Therapeutics, Inc. , a clinical stage company developing drugs that treat neurodegenerative disorders, today announced it will host a virtual KOL event on.